acquired
Stage
About
Abliva is a Swedish drug development company focused on treatments for rare primary mitochondrial diseases, working on orphan drugs and clinical trials.
Explore Abliva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.